Tag: Mindset Pharma - Page 5 - Psychedelic Alpha

Read more about the article Mindset Pharma Announces $5 Million Bought Deal Financing

Mindset Pharma Announces $5 Million Bought Deal Financing

Post published:March 22, 2021
Post category:Press Release

Read more about the article Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic Drug Candidates Pipeline With Novel DMT & 5-MeO-DMT Analogs

Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic Drug Candidates Pipeline With Novel DMT & 5-MeO-DMT Analogs

Post published:March 15, 2021
Post category:Press Release

Read more about the article Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds

Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds

Post published:February 5, 2021
Post category:Press Release

Read more about the article Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into in vivo PoC Studies

Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into in vivo PoC Studies

Post published:February 1, 2021
Post category:Press Release

Read more about the article Mindset Generates Promising In Vitro Results from Third Patent Family of Novel Psychedelic Compounds Suggesting Range of Potential Clinical Use Cases Including Micro-Dosing

Mindset Generates Promising In Vitro Results from Third Patent Family of Novel Psychedelic Compounds Suggesting Range of Potential Clinical Use Cases Including Micro-Dosing

Post published:January 6, 2021
Post category:Press Release

Read more about the article Mindset Engages Hybrid Financial Inc.

Mindset Engages Hybrid Financial Inc.

Post published:January 1, 2021
Post category:Press Release

Read more about the article Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized

Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized

Post published:December 29, 2020
Post category:Press Release

Read more about the article Mindset Pharma to Commence Trading on the CSE on December 23, 2020 Under the Symbol “MSET”

Mindset Pharma to Commence Trading on the CSE on December 23, 2020 Under the Symbol “MSET”

Post published:December 22, 2020
Post category:Press Release

Read more about the article Mindset Pharma Announces Closing of Non-Brokered Private Placement, Increasing Aggregate Gross Proceeds Raised to $5,000,000

Mindset Pharma Announces Closing of Non-Brokered Private Placement, Increasing Aggregate Gross Proceeds Raised to $5,000,000

Post published:December 17, 2020
Post category:Press Release

Read more about the article Mindset Pharma Announces Upsizing and Closing of $4.17 Million Brokered Private Placement Financing

Mindset Pharma Announces Upsizing and Closing of $4.17 Million Brokered Private Placement Financing

Post published:December 15, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.